Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
415 GBX | 0.00% | 0.00% | +5.87% |
Mar. 21 | Science Group hails "solid performance" despite profit drop | AN |
Mar. 21 | Earnings Flash (SAG.L) SCIENCE GROUP Posts FY23 Revenue GBP113.3M | MT |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 83.28 | 103.9 | 115.2 | 207.6 | 179.3 | 189.7 | 189.7 | - |
Enterprise Value (EV) 1 | 74.48 | 103.9 | 104.6 | 188.6 | 149.8 | 160.2 | 159 | 144.5 |
P/E ratio | 19.8 x | - | - | - | 17.5 x | 32.4 x | 18 x | 17.2 x |
Yield | 2.21% | 1.85% | 2.14% | 1.1% | 1.27% | 2.04% | 1.93% | 1.99% |
Capitalization / Revenue | 1.71 x | 1.81 x | 1.56 x | 2.56 x | 2.08 x | 1.57 x | 1.67 x | 1.63 x |
EV / Revenue | 1.53 x | 1.81 x | 1.42 x | 2.32 x | 1.74 x | 1.41 x | 1.4 x | 1.24 x |
EV / EBITDA | 8.77 x | 13.9 x | 7.81 x | 10.6 x | 7.85 x | 7.19 x | 6.92 x | 6.02 x |
EV / FCF | 14.3 x | - | 5.96 x | 14 x | 8.2 x | 15.7 x | 7.5 x | 7.24 x |
FCF Yield | 6.98% | - | 16.8% | 7.14% | 12.2% | 6.38% | 13.3% | 13.8% |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 40,040 | 41,710 | 41,134 | 45,616 | 45,402 | 45,717 | 45,717 | - |
Reference price 2 | 2.080 | 2.490 | 2.800 | 4.550 | 3.950 | 4.150 | 4.150 | 4.150 |
Announcement Date | 3/5/19 | 3/3/20 | 3/9/21 | 3/16/22 | 3/21/23 | 3/21/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 48.67 | 57.25 | 73.66 | 81.22 | 86.3 | 113.3 | 113.8 | 116.4 |
EBITDA 1 | 8.491 | 7.48 | 13.39 | 17.71 | 19.08 | 22.28 | 22.97 | 24.01 |
EBIT 1 | 7.731 | 6.704 | 10.88 | 16.26 | 17.6 | 20.54 | 20.99 | 22 |
Operating Margin | 15.88% | 11.71% | 14.78% | 20.02% | 20.4% | 18.12% | 18.44% | 18.9% |
Earnings before Tax (EBT) 1 | 4.867 | - | - | - | 11.1 | 7.619 | 13.9 | 14.6 |
Net income 1 | 4.287 | - | - | - | 10.56 | 5.524 | 10.5 | 11 |
Net margin | 8.81% | - | - | - | 12.23% | 4.87% | 9.22% | 9.45% |
EPS 2 | 0.1050 | - | - | - | 0.2260 | 0.1210 | 0.2300 | 0.2410 |
Free Cash Flow 1 | 5.2 | - | 17.54 | 13.47 | 18.27 | 10.22 | 21.2 | 19.96 |
FCF margin | 10.68% | - | 23.82% | 16.59% | 21.17% | 9.02% | 18.63% | 17.14% |
FCF Conversion (EBITDA) | 61.24% | - | 131% | 76.08% | 95.73% | 45.89% | 92.32% | 83.12% |
FCF Conversion (Net income) | 121.3% | - | - | - | 173.09% | 185.1% | 201.94% | 181.42% |
Dividend per Share 2 | 0.0460 | 0.0460 | 0.0600 | 0.0500 | 0.0500 | 0.0800 | 0.0800 | 0.0825 |
Announcement Date | 3/5/19 | 3/3/20 | 3/9/21 | 3/16/22 | 3/21/23 | 3/21/24 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - | - |
Net Cash position 1 | 8.8 | - | 10.6 | 19 | 29.5 | 18 | 30.7 | 45.3 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | 5.2 | - | 17.5 | 13.5 | 18.3 | 10.2 | 21.2 | 20 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | 0.44 | - | - | 4.86 | 0.09 | 0.08 | 0.5 | 0.6 |
Capex / Sales | 0.91% | - | - | 5.98% | 0.11% | 0.07% | 0.44% | 0.52% |
Announcement Date | 3/5/19 | 3/3/20 | 3/9/21 | 3/16/22 | 3/21/23 | 3/21/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.87% | 236M | |
+6.13% | 7.41B | |
-32.64% | 3.24B | |
+5.82% | 2.66B | |
+11.38% | 1.75B | |
-9.32% | 1.08B | |
+31.69% | 907M | |
-7.64% | 714M | |
-3.60% | 606M | |
-8.30% | 539M |
- Stock Market
- Equities
- SAG Stock
- Financials Science Group plc